Advances in Environmental Sciences - International Journal of the Bioflux Society
Online ISSN: 2066-7647
Print ISSN: 2066-7620
ISSN-L: 2066-7620
Published annually by Bioflux Publishing House.
Contact for submission:
Petrescu-Mag I. V. – ioan.mag@usamvcluj.ro
The journal covers all fields of environmental sciences,
connected to life sciences, geology, physics, chemistry, economics, policies,
or legislation (both theoretical and applied issues).
AES Bioflux offers an excellent opportunity to publish
original research articles, reviews, or short communications, both in print and
online, in color, open access. Our policy allows the author(s) to retain
copyright without restrictions. This is an open-access journal distributed
under the terms of the Creative Commons Attribution License (CC-BY), which
permits unrestricted use, distribution, and reproduction in any medium,
provided that the original author and source are properly credited.
AES Bioflux is an international peer-reviewed journal. Each
published article is independently evaluated by two Scientific Reviewers and at
least one linguist. The peer-review policy of AES Bioflux is double-blind peer
review. The editors use software to screen for plagiarism. Acceptance rate:
approximately 50%. Electronic submission is required.
Because many authors withdrew their manuscripts in final
form just before the payment of the publication fee, our policy was changed on
20 February 2019. The publication fee was replaced by a processing fee (250
USD), which is paid after a preliminary evaluation (not at the end of the
process).
Our evaluation process has two steps:
- Preliminary
evaluation by the editor (the author receives a preliminary acceptance or
rejection);
- External
double-blind peer review (at this stage, the author receives the final
decision: acceptance or rejection).
Please note that if the manuscript is not published, the
author or his/her institution receives a refund (except in cases of poor author
responsiveness, withdrawal, or rejection due to multiple submissions).
Authors are informed about the final decision (acceptance or
rejection) within 3–8 weeks after submission. The average overall time from
manuscript submission to publication is 10 weeks. Faster processing involves a
priority fee (50 USD).
Manuscript processing fee: 250 USD (or equivalent in
EURO or RON)
Manuscript processing fee with priority: 300 USD (or equivalent in EURO
or RON)
Publication fee: 0 USD
The journal has a waiver policy for authors from developing
countries (only in cases of very high-quality manuscripts). When the first
author of the manuscript is a member of the AES Bioflux Expanded Editorial
Board, no processing fee is required.
Please attach a scanned payment document and send it by
email to: ioan.mag@usamvcluj.ro
Payment details:
Bioflux SRL
SWIFT code: BTRLRO22
Account no.: 213USDCRT00L2861401
IBAN:
USD: RO68BTRL01302202L28614XX – BANCA TRANSILVANIA
(Cluj-Napoca)
EURO: RO19BTRL01304202L28614XX – BANCA TRANSILVANIA (Cluj-Napoca)
RON: RO44BTRL01301202L28614XX – BANCA TRANSILVANIA (Cluj-Napoca)
Statement of human and animal rights
When reporting experiments involving human subjects, authors
should indicate whether the procedures followed were in accordance with the
ethical standards of the responsible institutional and national committees on
human experimentation and with the Helsinki Declaration of 1975, as revised in
2000.
If there is doubt as to whether the research was conducted
in accordance with the Helsinki Declaration, authors must explain the rationale
for their approach and demonstrate that the institutional review body
explicitly approved the relevant aspects of the study.
When reporting experiments involving animals, authors should
indicate whether institutional and national guidelines for the care and use of
laboratory animals were followed (International Committee of Medical Journal
Editors – Uniform Requirements for Manuscripts Submitted to Biomedical
Journals, February 2006 – cited by PubMed/Medline).
Statement of informed consent
Patients have a right to privacy that should not be violated
without informed consent. Identifying information, including patients' names,
initials, or hospital numbers, should not be published in written descriptions,
photographs, or pedigrees unless essential for scientific purposes and written
informed consent has been obtained.
Informed consent requires that identifiable patients be
shown the manuscript prior to publication. Authors should identify individuals
who provided writing assistance and disclose the funding source for such
assistance.
Identifying details should be omitted whenever possible.
Complete anonymity is difficult to achieve, and informed consent should be
obtained whenever there is doubt. Masking the eye region in photographs is not
sufficient to guarantee anonymity.
If identifying characteristics are altered to protect
anonymity, authors must ensure that scientific meaning is not distorted and
editors should be informed accordingly (International Committee of Medical
Journal Editors – Uniform Requirements for Manuscripts Submitted to Biomedical
Journals, February 2006 – cited by PubMed/Medline).
Conflict-of-interest statement
Public trust in the peer-review process and the credibility
of published articles depend on the proper handling of conflicts of interest
during writing, peer review, and editorial decision-making.
A conflict of interest exists when an author, reviewer,
editor, or their institution has financial or personal relationships that could
inappropriately influence their actions. These relationships may range from
negligible to significant potential influence.
Financial relationships (employment, consultancies, stock
ownership, honoraria, paid expert testimony) are the most easily identifiable
conflicts and may undermine credibility.
Conflicts may also arise from personal relationships,
academic competition, or intellectual bias. The Chief Editor takes appropriate
measures to prevent such conflicts through established peer-review policies.
Authors’ responsibilities
- All
authors must have made significant contributions to the research
- Authors
must provide corrections or retractions if errors are identified
- Authors
must provide a complete list of references
- Information
on financial support must be included in the Acknowledgements section
- Submission
of the same research to more than one journal is prohibited
Peer-review, publication policies, and publication ethics
- Reviews
are conducted objectively and independently
- Reviewers
must have no conflicts of interest
- Manuscripts
are treated confidentially prior to publication
- Bioflux
Publishing takes reasonable measures to detect and prevent research
misconduct
- Allegations
of misconduct are handled appropriately by the publisher and editors
- Corrections,
clarifications, retractions, and apologies are accepted
- Corrections
cannot be made directly in the original published article; they must
appear as a separate Note or Erratum
- Retractions
are issued by the publisher in cases of plagiarism or serious ethical
concerns
This is an open-access journal distributed under the
Creative Commons Attribution License (CC-BY), permitting unrestricted use,
distribution, and reproduction, provided the original author and source are
credited.
If the journal ceases publication, Bioflux Publishing has
agreements with several databases authorized to preserve and republish archived
content in unlimited electronic and printed copies.
Bioflux Publishing is archived by the Legal Deposit of
Bucharest (National Library of Romania) and by the County Legal Deposit in
Cluj-Napoca (Octavian Goga Library).
Data Sharing Policy
1. Policy Statement
AES Bioflux is committed to
promoting transparency, reproducibility, and integrity in scientific research.
We support responsible data sharing as an essential component of scholarly
communication and encourage authors to make the data underlying their findings
openly available whenever possible.
This policy applies to all
manuscripts submitted to the journal and is consistent with international
standards for editorial best practices and research transparency.
2. Author Responsibilities
Authors are required to:
- Include
a Data Availability Statement in all submitted manuscripts.
- Clearly
indicate whether the data supporting the findings of the study are:
- Publicly
available,
- Available
upon reasonable request, or
- Restricted
due to ethical, legal, or confidentiality considerations.
- Ensure
that shared data are accurate, complete, and sufficiently documented to
allow replication and verification of the reported results.
Authors are strongly encouraged to deposit their data in recognized public repositories appropriate to their discipline.
3. Data Availability Statement
All manuscripts must include a
Data Availability Statement specifying one of the following:
- The
repository name, persistent identifier (e.g., DOI), and access link if
data are publicly available.
- The
conditions under which data may be accessed if restrictions apply.
- A
clear explanation if no new data were generated or analyzed.
Example statement:
"The data supporting the findings of this study are available in [repository name] at [DOI or URL], or from the corresponding author upon reasonable request."
4. Recommended Data
Repositories
Authors are encouraged to use
trusted repositories that provide:
- Persistent
identifiers (e.g., DOI)
- Long-term
preservation
- Public
accessibility
- Appropriate
metadata and documentation
Examples include institutional repositories, discipline-specific repositories, or general repositories such as Zenodo, Dryad, Figshare, or equivalent platforms.
5. Ethical and Legal
Considerations
Data sharing must comply with:
- Patient
privacy and confidentiality requirements
- Informed
consent provisions
- Institutional
and national regulations
- Ethical
approval conditions
Sensitive data involving human
participants must be de-identified prior to sharing, unless explicit consent
for identifiable data sharing has been obtained.
Where legal or ethical restrictions prevent public sharing, authors must clearly state these limitations.
6. Editorial and Peer Review
Access
Editors and peer reviewers may
request access to underlying data during the review process to evaluate the
scientific validity of the manuscript. Authors must provide such data upon
request, unless prohibited by legal or ethical constraints.
Failure to provide requested data may result in rejection of the manuscript.
7. Compliance and Enforcement
Failure to comply with this
policy may result in:
- Manuscript
rejection,
- Publication
delays,
- Retraction
of published articles if data integrity concerns arise.
The journal reserves the right to request data verification at any stage before or after publication.
8. Exceptions
Exceptions to data sharing
requirements may be granted in cases involving:
- Legal
restrictions,
- Ethical
or privacy concerns,
- Proprietary
or confidential data.
Such exceptions must be clearly justified in the Data Availability Statement.
9. Policy Scope and Alignment
This policy is aligned with
international editorial standards and supports the principles of:
- Research
transparency
- Reproducibility
- Scientific
integrity
- Responsible
data stewardship
The journal periodically reviews and updates this policy to maintain compliance with evolving indexing and ethical standards.
10. Contact Information
Questions regarding this policy
should be directed to the Editorial Office at:
ioan.mag@usamvcluj.ro
Advertising policy
Our journals do not accept or display any form of advertising, sponsored content, or commercial promotions. No third-party advertising networks are used, and there is no advertising revenue associated with our publications.
08.03.2009. 03:26
AES Bioflux
Page formatVolume 18(1)/2026 (December, 30)
Volume 17(1)/2025 (December, 30)
Volume 16(1)/2024 (December, 30)
Volume 15(2)/2023 (December, 30)
Volume 14(2)/2022 (December, 30)
Volume 13(3)/2021 (December, 30)
Volume 13(2)/2021 (August, 30)
Volume 12(3)/2020 (December, 30)
Volume 12(2)/2020 (August, 30)
Volume 11(3)/2019 (December, 30)
Volume 11(2)/2019 (August, 30)
Volume 10(3)/2018 (December, 30)
Volume 10(2)/2018 (August, 30)
Volume 9(3)/2017 (December, 30)
Volume 8(3)/2016 (December, 30)
Volume 7(3)/2015 (December, 30)
Volume 6(3)/2014 (December, 30)
Special Issue 2014 (March, 27)
Volume 5(3)/2013 (October, 15)
Volume 4(3)/2012 (December, 30)
Volume 3(3)/2011 (December, 30)
Volume 2(2)/2010 (November, 30)
Volume 1(2)/2009 (December, 30)
Volume Pilot (b)/2008 (December, 30) - available printed only
Volume Pilot (a)/2007 (December, 30) - available printed only
